Audra Boscoe

Audra Boscoe is an experienced professional in health economics and outcomes research, currently serving as Vice President at Agios Pharmaceuticals since April 2017, where responsibilities include building a specialized team for patient-reported outcomes and real-world evidence generation, along with leading initiatives in hematology-oncology, gastrointestinal oncology, neuro-oncology, and rare genetic diseases. Prior to Agios, Audra held the position of Director of Health Outcomes Research at Alexion Pharmaceuticals, focusing on various therapeutic areas, and served as Director of Health Economics & Outcomes Research at Genzyme, overseeing value evidence development for renal and multiple sclerosis products. Earlier roles include Senior Project Manager at United Biosource Corporation and Health Economics Scientist at AstraZeneca. Audra's academic credentials include a Ph.D. in Health Services Research from Johns Hopkins Bloomberg School of Public Health, an MPH from Yale School of Public Health, and a BA in Economics from William & Mary.